Alopecia patients finally have an FDA-approved hair-loss treatment

Ireland News News

Alopecia patients finally have an FDA-approved hair-loss treatment
Ireland Latest News,Ireland Headlines
  • 📰 PopSci
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 63%

The oral drug restored hair growth in about half of patients after a year.

Alopecia areata is an autoimmune disorder caused when the immune system attacks hair follicles, mistaking them as foreign invaders. The hair loss may begin as small circular bald patches around the head, but it can expand to larger overlapping patches.

The newly approved drug, Olumiant , is part of a class of drugs called JAK inhibitors. In two Phase III clinical trials, 32 percent of people with severe alopecia who took 4 milligrams of Olumiant tablets had 80 percent of their hair grow back after 9 months. After a year, almost half of the patients grew their hair back. JAK inhibitors are different from prior alopecia treatments because they target inflammation all over the body instead of just the scalp.

This style of treatment has another benefit, too: regrowing hair beyond the scalp. Alopecia also causes hair loss in the nose and ears, affecting a person’s hearing and allergies. A lack of eyelashes can promote eye irritation from dust freely entering the eye.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

PopSci /  🏆 298. in US

Ireland Latest News, Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves first alopecia treatment for condition that causes sudden hair lossFDA approves first alopecia treatment for condition that causes sudden hair lossThe drug — part of a class of medicines known as JAK inhibitors — is the first approved treatment for alopecia areata.
Read more »

FDA approves 1st drug treatment for alopecia hair lossFDA approves 1st drug treatment for alopecia hair lossThe FDA has approved Olumiant (baricitinib) as a treatment for alopecia areata hair loss following two randomized, double-blind, placebo-controlled trials.
Read more »

1st treatment for alopecia, autoimmune disorder causing hair loss, approved by FDA1st treatment for alopecia, autoimmune disorder causing hair loss, approved by FDAThe drug — part of a class of medicines known as JAK inhibitors — is the first approved treatment for alopecia areata.
Read more »

FDA approves drug to treat alopeciaFDA approves drug to treat alopeciaThe Food and Drug Administration approved an oral tablet to treat alopecia, a condition that causes hair loss.
Read more »

The FDA Has Approved Olumiant for the Treatment of Alopecia AreataThe FDA Has Approved Olumiant for the Treatment of Alopecia AreataThis is the first time a pill has been approved to treat the autoimmune condition that causes patchy hair loss and baldness.
Read more »

Breakthrough treatment for hair loss disorder shows promiseBreakthrough treatment for hair loss disorder shows promiseDr. Shikha Jain from UI Health talks about a potential breakthrough hair loss treatment, vaccines for children and heat-related illnesses.
Read more »



Render Time: 2025-03-04 22:00:32